Product Description
Diabetic retinopathy (DR), damage of the blood vessels in the retina, is one of the problems that patients may face as a complication of diabetes and is, along with other diabetic eye diseases, the greatest single cause of blindness in developed countries. This publication starts with the description of the mechanisms of development and progression of diabetic macular edema and with the characterization of the early stages of DR. An innovative approach of multimedial mapping methods which enables to differentiate between three DR phenotypes is further described. The standards and novel approaches of laser treatment as well as current surgical options and treatment techniques are discussed. Additional contributions consider the pathology of diffuse macular edema and the implications for surgery, the treatment of DR with triamcinolone and its complications, and the application of somatostatin analogues. A new therapeutic approach is the use of vascular endothelial growth factor inhibitors in diabetic macular edema. The volume concludes with articles on the latest concepts of posterior vitreous detachment by pharmacologic vitreolysis and the specific protein kinase C subtype inhibitor ruboxistaurin mesylate. To ophthalmologists and diabetes health care professionals interested in diabetic eye disease this book is an essential up-date.

SIMILAR PRODUCTS

Medical Retina (Essentials in Ophthalmology)
by Richard F. Spaide (Editor)

The specialty of medical retina remains one of the most challenging fields in ophthalmology. Fortunately, in the past few years the standard of knowledge in the area of medical retina has improved substantially. The insight in basic mechanisms of disease has been expanded and novel diagnostic and efficacious therapeutic strategies have been developed bridging the gap between laboratory and clinical science. For example, new developments in ophthalmic imaging have contributed significantly to...